Health & Medicine Johanna Bendell Call-on Congress panel speaker

1. THERE ARE SO MANYPROMISING AGENTS COMING TO TREAT COLORECTAL CANCERJohanna Bendell, MDDirector, GI Oncology Trials Sarah Cannon Research InstituteNashville, TN 2. What…

Documents Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill...

Slide 1Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill Mietlowski, Biometrics and Data Management, Novartis Oncology KOL Adaptive…

Documents ABSTRACT

ABSTRACT METHODS HYPOTHESES FINDINGS Background: Progression-free survival (PFS) has previously been established as a surrogate for overall survival (OS) based on individual…